<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Mesothelioma Journal Articles &#187; pleurodesis</title>
	<atom:link href="http://www.mesothelioma-line.com/articles/category/pleurodesis/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.mesothelioma-line.com/articles</link>
	<description>Journal Articles on Mesothelioma: Cancer Information for Patients and Families</description>
	<lastBuildDate>Wed, 15 Jun 2011 19:57:18 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases</title>
		<link>http://www.mesothelioma-line.com/articles/2008/12/18/medical-thoracoscopic-talc-pleurodesis-for-malignant-pleural-effusion-an-analysis-of-27-cases/</link>
		<comments>http://www.mesothelioma-line.com/articles/2008/12/18/medical-thoracoscopic-talc-pleurodesis-for-malignant-pleural-effusion-an-analysis-of-27-cases/#comments</comments>
		<pubDate>Thu, 18 Dec 2008 18:59:53 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Determining Efficacy]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pleural Effusion]]></category>
		<category><![CDATA[pleurodesis]]></category>
		<category><![CDATA[Symptoms & Symptom Management]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Type of Assessment:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/?p=1596</guid>
		<description><![CDATA[Beijing Da Xue Xue Bao. 2008 Dec 18;40(6):600-2. [Article in Chinese] [Link] Zhang W, Wang GF, Zhang H, Mu XD, Jin Z. Department of Respiratory Medicine, Peking University First Hospital, Beijing, China. Abstract Objective: To evaluate the efficacy and safety of talc poudrage pleurodesis via semi-rigid medical thoracoscopy in the treatment of malignant pleural effusions, [...]]]></description>
			<content:encoded><![CDATA[<p><em>Beijing Da Xue Xue Bao</em>. 2008 Dec 18;40(6):600-2. [Article in Chinese] [<a href="http://www.ncbi.nlm.nih.gov/pubmed/19088831?dopt=AbstractPlus">Link</a>]</p>
<p><strong>Zhang W, Wang GF, Zhang H, Mu XD, Jin Z.</strong></p>
<p>Department of Respiratory Medicine, Peking University First Hospital, Beijing, China.</p>
<h3>Abstract</h3>
<p><strong>Objective</strong>: To evaluate the efficacy and safety of talc poudrage pleurodesis via semi-rigid medical thoracoscopy in the treatment of malignant pleural effusions, as well as the factors that may influence the outcomes.</p>
<p><strong>Methods</strong>: A series of 27 patients with malignant pleural effusion underwent medical thoracoscopic talc poudrage pleurodesis between July 2005 and September 2007 in Peking University First Hospital.</p>
<p><strong>Results</strong>: There were 16 male and 11 female patients in the series, the average age being 65.2 years. All the patients had documented malignant pleural effusions, including 16 cases of adenocarcinoma, 6 of malignant mesothelioma, 2 of squamous cell carcinoma, 1 of lymphoepithelioma-like carcinoma, 1 of small cell carcinoma and 1 of undifferentiated lung cancer. Thirty days after the procedures, complete successful pleurodesis was achieved in 22 cases, and partial successful in 4 cases. Pleurodesis was not successful in one case. Overall successful rate was 96.3% (26/27). The average duration of thoracic tubing was 6.85 days. Chest pain, fever and an increase in peripheral WBC after the procedure occurred in 19(70.4%, 19/27), 21(77.8%, 21/27), and 12(44.4%, 12/27) cases respectively. No respiratory failure occurred.</p>
<p><strong>Conclusion</strong>: Medical thoracoscopic talc poudrage pleurodesis is a safe and effective method for the treatment of malignant pleural effusion.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2008/12/18/medical-thoracoscopic-talc-pleurodesis-for-malignant-pleural-effusion-an-analysis-of-27-cases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Recurrent pneumothorax as alone manifestation of mesothelioma pleurae</title>
		<link>http://www.mesothelioma-line.com/articles/2006/09/25/recurrent-pneumothorax-as-alone-manifestation-of-mesothelioma-pleurae/</link>
		<comments>http://www.mesothelioma-line.com/articles/2006/09/25/recurrent-pneumothorax-as-alone-manifestation-of-mesothelioma-pleurae/#comments</comments>
		<pubDate>Mon, 25 Sep 2006 15:57:07 +0000</pubDate>
		<dc:creator>Administrator</dc:creator>
				<category><![CDATA[Case Study]]></category>
		<category><![CDATA[Full Archive]]></category>
		<category><![CDATA[Pleural]]></category>
		<category><![CDATA[Pleural Effusion]]></category>
		<category><![CDATA[pleurodesis]]></category>
		<category><![CDATA[Symptoms & Symptom Management]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Type of Assessment:]]></category>
		<category><![CDATA[Type of Mesothelioma:]]></category>

		<guid isPermaLink="false">http://www.mesothelioma-line.com/articles/2006/09/25/recurrent-pneumothorax-as-alone-manifestation-of-mesothelioma-pleurae/</guid>
		<description><![CDATA[Pneumonologia i Alergologia Polska. 2005;73(3):281-4. [Link] Fijolek J, Wiatr E, Langfort R, Gawryluk D, Usiekniewicz J, Caban P, Orlowski TM, Szczepulska E, Opoka M, Malek G, Bestry I, Kazimierz-Sliz R. III Klinika Chorob Pluc, Warszawie. Abstract Malignant mesothelioma of the pleura is a rare neoplasm with a poor prognosis. The most often symptoms of this [...]]]></description>
			<content:encoded><![CDATA[<p><em>Pneumonologia i Alergologia Polska</em>. 2005;73(3):281-4. [<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&#038;cmd=Retrieve&#038;dopt=AbstractPlus&#038;list_uids=16989167&#038;itool=iconabstr&#038;itool=pubmed_DocSum" target="_blank">Link</a>] </p>
<p> Fijolek J, Wiatr E, Langfort R, Gawryluk D, Usiekniewicz J, Caban P, Orlowski TM, Szczepulska E, Opoka M, Malek G, Bestry I, Kazimierz-Sliz R. </p>
<p>III Klinika Chorob Pluc, Warszawie.</p>
<h3 class="abstract">Abstract</h3>
<p>Malignant mesothelioma of the pleura is a rare neoplasm with a poor prognosis. The most often symptoms of this disease are dyspnoe and chest wall pain, which is often associated with pleural effusion. We present 35-years old woman with 5 epizodes of pneumothorax during 3 years (4 of right side and 1-bilateral) in whom bilateral pleurodesis was performed. Specimens of lung and pleurae were examinated. Result of microscopic and immunohistochemical examination was: mesothelioma epithelioides pleurae (mesothelium +, calretyninaa +, EMA+ membrane reaction, desmine +/-).</p>
]]></content:encoded>
			<wfw:commentRss>http://www.mesothelioma-line.com/articles/2006/09/25/recurrent-pneumothorax-as-alone-manifestation-of-mesothelioma-pleurae/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

